[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

CH311610A - Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). - Google Patents

Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide).

Info

Publication number
CH311610A
CH311610A CH311610DA CH311610A CH 311610 A CH311610 A CH 311610A CH 311610D A CH311610D A CH 311610DA CH 311610 A CH311610 A CH 311610A
Authority
CH
Switzerland
Prior art keywords
anilide
methyl
isopropylamine
chloro
fatty acid
Prior art date
Application number
Other languages
German (de)
Inventor
Aktiengesellschaft Cilag
Original Assignee
Cilag Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cilag Ag filed Critical Cilag Ag
Publication of CH311610A publication Critical patent/CH311610A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/01Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/02Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Description

  

  



  Verfahren zur Herstellung eines neuen basisch substituierten   Fettsäure-     (2-halogen-6-methyl-anilids).



   Gegenstand des vorliegenden Patentes bildet ein Verfahren zur Herstellung eines neuen basisch substituierten   Fettsäure- (2-halogen-6-      methyl-anilids),    welches   dadllreh      gekennzeich-    net ist, da¯ man eine Verbindung der Formel
EMI1.1     
 in welcher X einen reaktionsfähigen, während der Reaktion sich   abspaltenden Best bedeutet,    mit Isopropylamin umsetzt.



   Der Rest X kann in einem Ha. logenatom oder einem sonstigen f r den   Austauseh    gegen den basischen   Rest geeigneten reaktionsfähi-    gen Substituenten, wie z. B. einer   Alkylsul-      fonyloxy-oder    Arylsulfonyloxygruppe, bestehen. Der   Austausch    der Gruppe X gegen den   Isopropylaminrest erfolgt    z. B. durch einfaches Erwärmen mit Isopropylamin gege  benenfalls    in Gegenwart eines basisch reagierenden Kondensationsmittels oder von Isopro  pylamin im Überschuss.    Das   Isopropyl-amino-    acet- (2-chlor-6-methyl-anilid) ist ein farbloses, unter 0, 01 mm Hg bei 132  siedendes Íl.

   Das   Hydroehlorid    der Base schmilzt bei   178-180 .   



   Das neue Anilid   salol    als   Lokalanästhetikum    und als Zwischenprodukt zur   Herstellung    wei  terer Derivate Verwendung    finden.



   Beispiel :
36 Gewichtsteile Chloracet-   (2-chlor-6-me-      thyl-anilid)    (gewonnen durch Umsetzen von 2  Chlor-6-methyl-anilin    mit   Chloraeetylchlorid    in Gegenwart von Natriumacetat, Schmp. 140 bis 141 ) werden in 200 Gewichtsteilen wϯriger   60 /oiger Isopropylaminlösung suspen-    diert. Die Temperatur steigt dabei leicht an, und ein grosser Teil des Reaktionsgemisches geht in L¯sung. Nun wird während 4 Stunden bei Zimmertemperatur gerührt, und dann einige Stunden in geschlossenem Gefäss bei   100-120 .    Eine Probe mit Wasser und nachfolgend mit verdünnter SalzsÏure versetzt ergibt wieder   Losung    des ausgefallenen Niederschlages.

   Mit Wasserdampf wird hierauf der Alkohol und das übersehüssige Isopropylamin abgeblasen und nach dem Erkalten das   zu-      rückbleibende      Ol    in   ather    aufgenommen. Nach dem Trocknen der ätherischen Lösung und d Verjagen des   Losungsmittels    verbleibt ein   öl,    das durch Vakuumdestillation gereinigt wird.



  Man erhält 35 Gewiehtsteile reines Isopropyl  aminoa. cet- (2-chlor-6-methyl-anilid).    Die Umsetzung mit Isopropylamin kann auch in   Ben-      zol stattfinden.     



   PATENTANSPRUCH :
Verfahren zur Herstellung eines neuen basisch substituierten FettsÏure- (2-halogen-6methyl-anilids), dadurch gekennzeichnet, daR man eine Verbindung der Formel 

**WARNUNG** Ende DESC Feld konnte Anfang CLMS uberlappen**.





  



  Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide).



   The subject of the present patent is a process for the preparation of a new basic substituted fatty acid (2-halo-6-methyl-anilide), which is marked as a compound of the formula
EMI1.1
 in which X denotes a reactive Best which is split off during the reaction, reacts with isopropylamine.



   The rest of X can be in a Ha. logenatom or any other reactive substituents suitable for exchange with the basic radical, such as B. an alkylsulfonyloxy or arylsulfonyloxy group exist. The exchange of group X against the isopropylamine residue takes place, for. B. by simply heating with isopropylamine, if necessary, in the presence of a basic condensing agent or isopropylamine in excess. Isopropyl-amino-acet- (2-chloro-6-methyl-anilide) is a colorless oil that boils below 0.01 mm Hg at 132.

   The hydrochloride of the base melts at 178-180.



   The new anilide salol can be used as a local anesthetic and as an intermediate product for the production of further derivatives.



   Example:
36 parts by weight of chloroacet- (2-chloro-6-methyl-anilide) (obtained by reacting 2-chloro-6-methyl-aniline with chloroethyl chloride in the presence of sodium acetate, melting point 140 to 141) are aqueous in 200 parts by weight 60% isopropylamine solution suspended. The temperature rises slightly and a large part of the reaction mixture goes into solution. The mixture is then stirred for 4 hours at room temperature, and then for a few hours in a closed vessel at 100-120. A sample with water and then mixed with dilute hydrochloric acid results in a solution of the precipitate.

   The alcohol and the excess isopropylamine are then blown off with steam and, after cooling, the remaining oil is absorbed in ether. After the ethereal solution has dried and the solvent has been driven off, an oil remains which is purified by vacuum distillation.



  35 parts by weight of pure isopropyl aminoa are obtained. cet- (2-chloro-6-methyl-anilide). The reaction with isopropylamine can also take place in benzene.



   PATENT CLAIM:
Process for the preparation of a new basic substituted fatty acid (2-halogen-6methyl-anilide), characterized in that a compound of the formula

** WARNING ** End of DESC field could overlap beginning of CLMS **.



 

Claims (1)

**WARNUNG** Anfang CLMS Feld konnte Ende DESC uberlappen **. ** WARNING ** Beginning of CLMS field could overlap end of DESC **. Verfahren zur Herstellung eines neuen basisch substituierten Fettsäure- (2-halogen-6-methyl-anilids). Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). Gegenstand des vorliegenden Patentes bildet ein Verfahren zur Herstellung eines neuen basisch substituierten Fettsäure- (2-halogen-6- methyl-anilids), welches dadllreh gekennzeich- net ist, da¯ man eine Verbindung der Formel EMI1.1 in welcher X einen reaktionsfähigen, während der Reaktion sich abspaltenden Best bedeutet, mit Isopropylamin umsetzt. The subject of the present patent is a process for the preparation of a new basic substituted fatty acid (2-halo-6-methyl-anilide), which is marked as a compound of the formula EMI1.1 in which X denotes a reactive Best which is split off during the reaction, reacts with isopropylamine. Der Rest X kann in einem Ha. logenatom oder einem sonstigen f r den Austauseh gegen den basischen Rest geeigneten reaktionsfähi- gen Substituenten, wie z. B. einer Alkylsul- fonyloxy-oder Arylsulfonyloxygruppe, bestehen. Der Austausch der Gruppe X gegen den Isopropylaminrest erfolgt z. B. durch einfaches Erwärmen mit Isopropylamin gege benenfalls in Gegenwart eines basisch reagierenden Kondensationsmittels oder von Isopro pylamin im Überschuss. Das Isopropyl-amino- acet- (2-chlor-6-methyl-anilid) ist ein farbloses, unter 0, 01 mm Hg bei 132 siedendes Íl. The rest of X can be in a Ha. logenatom or any other reactive substituents suitable for exchange with the basic radical, such as B. an alkylsulfonyloxy or arylsulfonyloxy group exist. The exchange of group X against the isopropylamine residue takes place, for. B. by simply heating with isopropylamine, if necessary, in the presence of a basic condensing agent or isopropylamine in excess. Isopropyl-amino-acet- (2-chloro-6-methyl-anilide) is a colorless oil that boils below 0.01 mm Hg at 132. Das Hydroehlorid der Base schmilzt bei 178-180 . The hydrochloride of the base melts at 178-180. Das neue Anilid salol als Lokalanästhetikum und als Zwischenprodukt zur Herstellung wei terer Derivate Verwendung finden. The new anilide salol can be used as a local anesthetic and as an intermediate product for the production of further derivatives. Beispiel : 36 Gewichtsteile Chloracet- (2-chlor-6-me- thyl-anilid) (gewonnen durch Umsetzen von 2 Chlor-6-methyl-anilin mit Chloraeetylchlorid in Gegenwart von Natriumacetat, Schmp. 140 bis 141 ) werden in 200 Gewichtsteilen wϯriger 60 /oiger Isopropylaminlösung suspen- diert. Die Temperatur steigt dabei leicht an, und ein grosser Teil des Reaktionsgemisches geht in L¯sung. Nun wird während 4 Stunden bei Zimmertemperatur gerührt, und dann einige Stunden in geschlossenem Gefäss bei 100-120 . Eine Probe mit Wasser und nachfolgend mit verdünnter SalzsÏure versetzt ergibt wieder Losung des ausgefallenen Niederschlages. Example: 36 parts by weight of chloroacet- (2-chloro-6-methyl-anilide) (obtained by reacting 2-chloro-6-methyl-aniline with chloroethyl chloride in the presence of sodium acetate, melting point 140 to 141) are aqueous in 200 parts by weight 60% isopropylamine solution suspended. The temperature rises slightly and a large part of the reaction mixture goes into solution. The mixture is then stirred for 4 hours at room temperature, and then for a few hours in a closed vessel at 100-120. A sample with water and then mixed with dilute hydrochloric acid results in a solution of the precipitate. Mit Wasserdampf wird hierauf der Alkohol und das übersehüssige Isopropylamin abgeblasen und nach dem Erkalten das zu- rückbleibende Ol in ather aufgenommen. Nach dem Trocknen der ätherischen Lösung und d Verjagen des Losungsmittels verbleibt ein öl, das durch Vakuumdestillation gereinigt wird. The alcohol and the excess isopropylamine are then blown off with steam and, after cooling, the remaining oil is absorbed in ether. After the ethereal solution has dried and the solvent has been driven off, an oil remains which is purified by vacuum distillation. Man erhält 35 Gewiehtsteile reines Isopropyl aminoa. cet- (2-chlor-6-methyl-anilid). Die Umsetzung mit Isopropylamin kann auch in Ben- zol stattfinden. 35 parts by weight of pure isopropyl aminoa are obtained. cet- (2-chloro-6-methyl-anilide). The reaction with isopropylamine can also take place in benzene. PATENTANSPRUCH : Verfahren zur Herstellung eines neuen basisch substituierten FettsÏure- (2-halogen-6methyl-anilids), dadurch gekennzeichnet, daR man eine Verbindung der Formel EMI2.1 in welcher X einen reaktionsfähigen, während der Reaktion sich abspaltenden Rest bedeutet, mit Isopropylamin umsetzt. Das auf diese Weise erhaltene Isopropylaminoacet- (2-chlor- 6-methyl-anilid) bildet ein farbloses, unter 0, 01 mm Hg bei 132¯ siedendes Íl. Das Hydrochlorid der Base schmilzt bei 178-180 . PATENT CLAIM: Process for the preparation of a new basic substituted fatty acid (2-halogen-6methyl-anilide), characterized in that a compound of the formula EMI2.1 in which X is a reactive radical which is split off during the reaction, is reacted with isopropylamine. The isopropylaminoacet- (2-chloro-6-methyl-anilide) obtained in this way forms a colorless oil that boils below 0.01 mm Hg at 132¯. The base hydrochloride melts at 178-180. Das neue Anilid soll als LokalanÏsthetikum und als Zwischenprodukt. Verwendung finden. The new anilide is said to be used as a local anÏesthetic and as an intermediate. Find use. UNTERANSPRUCH : Verfahren nach Patentanspruch, dadurch gekennzeiehnet, dass man ein Halogenacet- (2 chlor-6-methyl-anilid) mit Isopropylamin re agieren lϯt. SUBClaim: Process according to patent claim, characterized in that a haloacet (2 chloro-6-methyl-anilide) is allowed to react with isopropylamine.
CH311610D 1952-02-25 1952-02-25 Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). CH311610A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH311610T 1952-02-25
CH307799T 1952-11-25

Publications (1)

Publication Number Publication Date
CH311610A true CH311610A (en) 1955-11-30

Family

ID=25735343

Family Applications (1)

Application Number Title Priority Date Filing Date
CH311610D CH311610A (en) 1952-02-25 1952-02-25 Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide).

Country Status (1)

Country Link
CH (1) CH311610A (en)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10780083B1 (en) 2019-03-11 2020-09-22 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US10786485B1 (en) 2019-03-11 2020-09-29 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US10842798B1 (en) 2019-11-06 2020-11-24 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US10927096B2 (en) 2019-03-11 2021-02-23 Nocion Therapeutics, Inc. Ester substituted ion channel blockers and methods for use
US10933055B1 (en) 2019-11-06 2021-03-02 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US10934263B2 (en) 2019-03-11 2021-03-02 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US10968179B2 (en) 2019-03-11 2021-04-06 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US11332446B2 (en) 2020-03-11 2022-05-17 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US12162851B2 (en) 2020-03-11 2024-12-10 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use

Cited By (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11643404B2 (en) 2019-03-11 2023-05-09 Nocion Therapeutics, Inc. Ester substituted ion channel blockers and methods for use
US11377422B2 (en) 2019-03-11 2022-07-05 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US10828287B2 (en) 2019-03-11 2020-11-10 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US12195428B2 (en) 2019-03-11 2025-01-14 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US10927096B2 (en) 2019-03-11 2021-02-23 Nocion Therapeutics, Inc. Ester substituted ion channel blockers and methods for use
US10780083B1 (en) 2019-03-11 2020-09-22 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US10786485B1 (en) 2019-03-11 2020-09-29 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US10934263B2 (en) 2019-03-11 2021-03-02 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US11603355B2 (en) 2019-03-11 2023-03-14 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US10968179B2 (en) 2019-03-11 2021-04-06 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US11512058B2 (en) 2019-03-11 2022-11-29 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US10933055B1 (en) 2019-11-06 2021-03-02 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US11696912B2 (en) 2019-11-06 2023-07-11 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US10842798B1 (en) 2019-11-06 2020-11-24 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US11332446B2 (en) 2020-03-11 2022-05-17 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US12162851B2 (en) 2020-03-11 2024-12-10 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use

Similar Documents

Publication Publication Date Title
CH311610A (en) Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide).
CH311606A (en) Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide).
CH311613A (en) Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide).
CH311609A (en) Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide).
CH311608A (en) Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide).
CH311612A (en) Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide).
CH311614A (en) Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide).
CH311607A (en) Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide).
CH311615A (en) Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide).
CH311604A (en) Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide).
CH311629A (en) Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide).
CH311605A (en) Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide).
CH311603A (en) Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide).
CH311621A (en) Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide).
CH312572A (en) Process for the preparation of a new basic substituted fatty acid (2-halo-6-methyl) anilide
CH311630A (en) Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide).
CH311644A (en) Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide).
CH311627A (en) Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide).
CH311639A (en) Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide).
CH311642A (en) Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide).
CH311632A (en) Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide).
CH311624A (en) Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide).
CH311631A (en) Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide).
CH328671A (en) Process for the production of a new basic substituted fatty acid-2-halogen-6-methyl-anilide
CH311619A (en) Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide).